Eitr Biologics
Blood & Organ Banks · 11-50 Employees
View Company Info for Free
Overview
Website
www.eitrbio.comRevenue
<$5 MillionIndustry
About Eitr Biologics
Eitr Biologics specializes in the development of innovative immunotherapeutics through its Orthogonal Dual-Interacting Nanotherapeutic (ODIN) platform, which focuses on single domain antibody-based technologies. The company aims to create highly potent treatments for oncology, antibacterials, and antivirals, leveraging the unique capabilities of its ODIN molecules to penetrate challenging biological barriers. Their approach emphasizes smaller, faster, and cheaper solutions to enhance therapeutic efficacy. Eitr Biologics targets a range of clients in the pharmaceutical and biotechnology sectors seeking advanced therapeutic options.Explore more
SIC Code 28,283NAICS Code 32,325Show moreEitr Biologics Org Chart
Compare Similar Companies to Eitr Biologics
Compare insights from companies similar to Eitr Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Eitr Biologics Tech Stack
A closer look at the technologies used by Eitr Biologics
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eitr Biologics
Sign Up For FreeTo access detailed company insights
Eitr Biologics specializes in the development of innovative immunotherapeutics through its Orthogonal Dual-Interacting Nanotherapeutic (ODIN) platform, which focuses on single domain antibody-based technologies. The company aims to create highly potent treatments for oncology, antibacterials, and antivirals, leveraging the unique capabilities of it... Read More
